This week, we spoke with all three of CURE’s 2019 Ovarian Cancer Heroes: Ryan Mitstifer Walton, Paula Anastasia, RN, MN, AOCN, and Shannon Westin, M.D., M.P.H.
What do a 16-year-old advocate, one patient’s “tear catcher” and a Moon Shot doctor all have in common? They were all recognized by CURE as the 2019 Ovarian Cancer Heroes for their innovative research and dedication to raising awareness for patients with the disease.
In this week’s episode, we spoke with ovarian cancer advocate Ryan Mitstifer Walton, gynecologic oncology nurse Paula Anastasia, RN, MN, AOCN, and Shannon Westin, M.D., M.P.H., of The University of Texas MD Anderson.
To read more about the Ovarian Cancer Heroes event, visit curetoday.com.
Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research
March 4th 2024In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, and how to manage them.
Listen
FDA Prioritizes Review of Elahere in Ovarian Cancer
December 13th 2023The Food and Drug Administration has set priority review for Elahrere as use of treatment in patients with folate receptor alpha (FRα)-positive, platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Read More